Enhanced Surveillance and Control of Endemic and Emerging Arboviruses in Puerto Rico

Closed Posted

Opportunity number
RFA-CK-25-182
Agency
Applications due
Award size
$500,000 to $5,000,000

Opportunity facts

Funding instrument
Cooperative Agreement
Category
  • Health
Eligible applicants
  • Other

Opportunity details come from Grants.gov. Updated .

About this opportunity

This federal grant opportunity from the Centers for Disease Control and Prevention (CDC) seeks to strengthen an established research platform for arboviruses in hospital and community settings in Puerto Rico. The key objectives are to enhance hospital-based surveillance of acute febrile illness to detect emerging arboviruses, conduct clinical research on dengue and other arboviral diseases, maintain a community cohort to assess disease prevalence and evaluate vector control strategies, modernize data management infrastructure, and strengthen collaborations with local stakeholders. Only the Ponce Medical School Foundation Inc. at Ponce Health Sciences University is eligible to apply, as they have an established surveillance infrastructure through previous CDC cooperative agreements. Applications are due by February 28, 2025, with a letter of intent requested by January 28, 2025.

The cooperative agreement provides $25 million in funding over 5 years ($5 million per year from September 1, 2025 to August 31, 2030) for one recipient. The work will primarily be conducted in Puerto Rico, leveraging the existing surveillance platform and community partnerships.

Synopsis

The purpose of this notice of funding opportunity (NOFO) is to strengthen an established research platform for arboviruses in hospital and community settings in Puerto Rico, identify emerging and endemic pathogens like dengue and Oropouche viruses, improve patient management, and evaluate prevention and control strategies. The core objectives include: 1) strengthen hospital surveillance of acute febrile illness (AFI) to ensure early detection of emerging arboviruses and other pathogens; 2) use the established AFI surveillance platform to conduct clinical research on dengue and other arboviral diseases, including among special populations such as women and children; 3) maintain and enhance the community cohort to assess incidence and prevalence of arboviral infections and other AFIs, while also evaluate the effectiveness of vector control strategies; 4) strengthen and modernize infrastructure for project data management and analysis, ensuring the surveillance platform is capable of handling large, complex datasets in real-time; and 5) strengthen collaborations with the local government, community leaders, and other interest holders to ensure the continuity of the established program while fostering an environment of rapid and effective communication and cooperation.

Files

File Type Posted
RFA-CK-25-182_20241227.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity